J. Clark

1.2k total citations
25 papers, 987 citations indexed

About

J. Clark is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Clark has authored 25 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Otorhinolaryngology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Clark's work include Head and Neck Cancer Studies (10 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Treatment and Pharmacology (4 papers). J. Clark is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Treatment and Pharmacology (4 papers). J. Clark collaborates with scholars based in United States, United Kingdom and Canada. J. Clark's co-authors include Marshall R. Posner, Charles M. Norris, Stephen T. Sonis, Thomas J. Ervin, Paul M. Busse, Régis Costello, Daniel Miller, J. Lucarini, Arnon I. Dreyfuss and Barbara G. Fallon and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J. Clark

25 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Clark United States 15 484 435 363 345 151 25 987
I. Benjamin Paz United States 15 607 1.3× 388 0.9× 251 0.7× 677 2.0× 248 1.6× 48 1.4k
George Plataniotis Greece 16 352 0.7× 195 0.4× 247 0.7× 238 0.7× 112 0.7× 40 1.1k
John Showel United States 13 397 0.8× 520 1.2× 315 0.9× 398 1.2× 134 0.9× 23 1.0k
Sandra Schmitz Belgium 21 614 1.3× 483 1.1× 385 1.1× 504 1.5× 389 2.6× 67 1.4k
A Rey France 9 707 1.5× 926 2.1× 642 1.8× 758 2.2× 345 2.3× 11 1.7k
Dirk Van Gestel Belgium 20 439 0.9× 318 0.7× 502 1.4× 230 0.7× 178 1.2× 88 1.2k
Magid H. Amer Saudi Arabia 15 495 1.0× 154 0.4× 449 1.2× 203 0.6× 277 1.8× 28 1.2k
Franco Mattavelli Italy 17 291 0.6× 154 0.4× 190 0.5× 530 1.5× 89 0.6× 42 921
P. Sebastian India 14 232 0.5× 208 0.5× 178 0.5× 210 0.6× 93 0.6× 29 699
Jeannie J. Kinzie United States 21 652 1.3× 453 1.0× 687 1.9× 715 2.1× 142 0.9× 35 1.8k

Countries citing papers authored by J. Clark

Since Specialization
Citations

This map shows the geographic impact of J. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Clark more than expected).

Fields of papers citing papers by J. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Clark. The network helps show where J. Clark may publish in the future.

Co-authorship network of co-authors of J. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of J. Clark. A scholar is included among the top collaborators of J. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Clark. J. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Joanne, et al.. (2012). Factors Associated With Prolonged Gastrostomy Tube Usage in Patients With Oropharyngeal Cancer Treated With Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 84(3). S479–S479. 1 indexed citations
2.
Goldsmith, Tessa, Elizabeth A. Weyman, Paul M. Busse, et al.. (2012). Swallowing Function After Proton Beam Therapy for Nasopharyngeal Cancer: A Prospective Study. International Journal of Radiation Oncology*Biology*Physics. 84(3). S62–S63. 1 indexed citations
3.
Camidge, D. Ross, J. A. Engelman, J. Clark, et al.. (2012). Clinical Activity of Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring Ros1 Gene Rearrangement. Annals of Oncology. 23. ix389–ix389. 16 indexed citations
4.
Lampejo, Temi, J. Clark, Robert Goldin, et al.. (2010). Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review. British Journal of Cancer. 103(12). 1858–1869. 43 indexed citations
5.
Wirth, Lori J., Aaron M. Allen, Marshall R. Posner, et al.. (2009). Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck. Annals of Oncology. 21(2). 342–347. 47 indexed citations
6.
Wirth, Lori J., Marshall R. Posner, Roy B. Tishler, et al.. (2008). Phase I study of panitumumab + chemoradiotherapy (CRT) for head and neck cancer (HNC). Journal of Clinical Oncology. 26(15_suppl). 6007–6007. 10 indexed citations
7.
Wirth, Lori J., Marshall R. Posner, Roy B. Tishler, et al.. (2007). Phase I study of panitumumab, chemotherapy and intensity-modulated radiotherapy (IMRT) for head and neck cancer (HNC): Early results. Journal of Clinical Oncology. 25(18_suppl). 6083–6083. 13 indexed citations
8.
Bourquin, Jean‐Pierre, Ian Thornley, Donna Neuberg, et al.. (2004). Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhood. Bone Marrow Transplantation. 34(9). 795–798. 15 indexed citations
9.
Misset, J.L., Miguel A. Villalona‐Calero, D. P. Ryan, et al.. (1999). Phase I trials with ET-743, a marine derived (MD) anticancer agent. European Journal of Cancer. 35. S283–S283. 1 indexed citations
10.
Clark, J., Paul M. Busse, Charles M. Norris, et al.. (1997). Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.. Journal of Clinical Oncology. 15(9). 3100–3110. 48 indexed citations
12.
Ferrans, V J, et al.. (1997). Pathogenesis and prevention of doxorubicin cardiomyopathy.. PubMed. 39(10). 928–37. 55 indexed citations
13.
Dreyfuss, Arnon I., J. Clark, Charles M. Norris, et al.. (1996). Docetaxel: an active drug for squamous cell carcinoma of the head and neck.. Journal of Clinical Oncology. 14(5). 1672–1678. 192 indexed citations
14.
Swann, R A & J. Clark. (1994). Antibiotic policies--relevance to general practitioner prescribing. Journal of Antimicrobial Chemotherapy. 33(suppl A). 131–135. 9 indexed citations
15.
Sonis, Stephen T. & J. Clark. (1991). Prevention and management of oral mucositis induced by antineoplastic therapy.. PubMed. 5(12). 11–8; discussion 18. 92 indexed citations
16.
Lockhart, Peter B. & J. Clark. (1990). Oral complications following neoadjuvant chemotherapy in patients with head and neck cancer.. PubMed. 99–101. 22 indexed citations
17.
Herman, Terence S., Beverly A. Teicher, Maxine S. Jochelson, et al.. (1988). Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. International Journal of Hyperthermia. 4(2). 143–158. 124 indexed citations
18.
Clark, J. & J B Wheelock. (1988). Angiokeratoma of the vulva. A case report.. PubMed. 33(5). 473–4. 6 indexed citations
19.
Strome, Marshall, et al.. (1987). T-Cell Subsets and Natural Killer Cell Function With Squamous Cell Carcinoma of the Head and Neck. Archives of Otolaryngology - Head and Neck Surgery. 113(10). 1090–1093. 14 indexed citations
20.
Frei, Emil, Daniel Miller, J. Clark, Barbara G. Fallon, & Thomas J. Ervin. (1986). Clinical and Scientific Considerations in Preoperative (Neoadjuvant) Chemotherapy. Recent results in cancer research. 103. 1–5. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026